His research at Halodine focuses on dilute povidone iodine, its ability to rapidly inactivate the SARS-CoV-2 virus, and its application in high-risk professions and populations to help reduce the risk of transmission via oral and nasal antisepsis.  In vivo data from other countries such as Spain, Japan, and Malaysia are promising.  His team strives to provide another layer of protection for our colleagues and loved ones and hope to be part of the solution against this and future pandemics.